Recent functional analyses of genetically engineered mouse models further demonstrated that Epac1 deficiency resulted in reduced susceptibility to atrial fibrillation (the most common sustained cardiac arrhythmia) and ventricular arrhythmia [58]. This evidence concerns the gene RAPGEF3 and cardiac arrhythmia.